21 Reagents, Reference Materials & Laboratory Chemicals
High-purity exosome standards improve EV research reproducibility
Amsbio introduces a comprehensive range of lyophilised exosome standards designed to enhance reproducibility and standardisation in extracellular vesicle (EV) studies.
Exosomes - tiny lipid nanoparticles secreted by most living cells - play crucial roles in various physiological and pathological processes. Their involvement in cancer, infectious diseases, and neurodegenerative disorders has sparked growing interest in their potential as biomarkers and therapeutic agents.
As the importance of reproducible extracellular vesicle (EV) research gains global recognition, the International Society for Extracellular Vesicles (ISEV) highlighted this focus in its 2023 guidelines. Amsbio’s exosome standards directly support these priorities by providing high-purity, quality-controlled reference materials that enable consistent comparison across laboratories and studies. To learn more about how exosomes are advancing diagnostics and therapeutics - and the crucial role of standards in this progress - read Amsbio’s detailed blog:
ilmt.co/PL/8o7o
Sourced from diverse biological materials - including cell culture supernatant, human plasma, serum, and urine - Amsbio exosomes undergo rigorous purification via tangential flow filtration (TFF) and size exclusion chromatography (SEC). Each batch is thoroughly characterised for protein content, size distribution, particle concentration, and expression of EV-specific markers.
Freeze-dried to maintain structural integrity, these standards remain stable at 4°C for up to 36 months. Their stringent quality control supports reliable experimental outcomes and cross-study comparability.
Quick to reconstitute, Amsbio exosome standards serve as trusted positive controls in applications such as marker validation, EV quantification, flow cytometry, immunocapture testing, and OMICS analyses. Fluorescent labelling options are also available.
More information online:
ilmt.co/PL/Z1KO 65280pr@reply-direct.com
High purity solvents, HPLC - LCMS
With the recent supply chain issues as a result of the pandemic and Brexit, severely impacting product availability and delivery times, Atom Scientific offers a comprehensive range of high purity solvents, including Glass Distilled, HPLC, LCMS and other more specialists grades. They are manufactured in the UK, stocked in Manchester and available for next day delivery throughout the UK and available for export.
The manufacturing process enables us to have full traceability from original manufacture to end product fulfilment, each batch is tested individually to ensure tight specification parameters are adhered to.
If you do not require such high specification material, then Atom Scientific also offers a complete range of ACS Grade products, which are bottled in their Manchester facility and available for next day shipment/delivery.
More information online:
ilmt.co/PL/EOQy and
ilmt.co/PL/w1J9 59725pr@reply-direct.com
ADVERTORIAL Advancing diagnostic innovation with custom lyophilised formats
As diagnostics continue to shift toward decentralised and point-of-care (POC) settings, the demand for stable, easy-to-use reagent formats has never been higher. Biopharma Group CDMO scientists specialise in delivering custom lyophilised solutions designed to meet the unique needs of diagnostic developers worldwide.
In-house expertise and facilities mean that both lyobead and lyocake formats are available, providing fl exible formats that integrate seamlessly into a range of devices, everything from multi-chamber cartridges to fl at reaction chambers. Our solutions support a broad array of applications, including qPCR, RT-LAMP, isothermal amplifi cation, and molecular diagnostics.
What sets Biopharma Group apart is a fully collaborative approach. The diagnostics team will work closely with customers at every stage, from feasibility and R&D batches to validation and full commercial production. The team brings technical expertise in formulation, lyophilisation, and analytical characterisation, ensuring each reagent product delivers the required performance and stability.
Flexible manufacturing capabilities mean Biopharma Group can accommodate the changing needs of diagnostic innovators, whether supporting early-stage development, navigating scale-up, or responding to shifting market demands. Importantly, all diagnostics CDMO services are fully supported with robust quality and regulatory support, helping de-risk projects and accelerate time to market.
Biopharma Group is proud to partner with diagnostic leaders to bring reliable, high- performing solutions to patients and healthcare providers worldwide. Whether you’re looking for custom lyobeads, lyocakes, or end-to-end technical collaboration, Biopharma Group is here to help turn your vision into reality.
Discover more from your lyo CDMO partners today.
More information online:
ilmt.co/PL/KwYA and
ilmt.co/PL/nXmw 65413pr@reply-direct.com
BTL 204 Reagents Spot HP ILM print
FINAL.indd 1 29/07/2025 00:16
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60
